Daniel Billen - May 18, 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Daniel Billen, Ph.D.
Stock symbol
AUPH
Transactions as of
May 18, 2023
Transactions value $
-$52,359
Form type
4
Date filed
5/23/2023, 05:17 PM
Previous filing
May 20, 2022
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Options Exercise +8.73K +43.67% 28.7K May 18, 2023 Direct F1
transaction AUPH Common Stock Award $0 +9.31K +32.4% $0.00 38K May 19, 2023 Direct F2
transaction AUPH Common Stock Sale -$52.4K -4.65K -12.22% $11.26 33.4K May 23, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Options Exercise $0 -8.73K -100% $0.00* 0 May 18, 2023 Common Stock 8.73K Direct F1
transaction AUPH Stock Option (right to buy) Award $0 +15.2K $0.00 15.2K May 19, 2023 Common Stock 15.2K $10.74 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
F2 Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
F3 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
F4 The option vests in twelve equal monthly installments commencing on June 19, 2023.